CatalystPit

NGNENeurogene Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $27.82 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$556.72M
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-02 · McMinn Rachel (Chief Executive Officer) · OTHER
  • 2026-07-07 · Cvijic Christine Mikail (President and CFO) · SELL
  • 2026-07-02 · Cvijic Christine Mikail (President and CFO) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders120
Shares held19,452,178
Value$611.38M
Percent of shares outstanding97.21%
As of quarter end2026-06-30
RECENT NEWS
  • Neurogene is a new Overweight at J.P. Morgan on Rett syndrome therapy
  • JPMorgan initiates Neurogene stock rating at Overweight on gene therapy potential
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS